Kronos Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Kronos Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2024.
Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.03M, a 67.8% decline year-over-year.
Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $17.1M, a 37.8% decline year-over-year.
Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25M, a 19.8% decline from 2022.
Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.1M, a 18.8% increase from 2021.
Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.2M, a 598% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$17.1M	$2.03M	-$4.27M	-67.8%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$21.4M	$2.2M	-$4.7M	-68.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$26.1M	$7.71M	+$1.1M	+16.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$25M	$5.17M	-$2.52M	-32.7%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-21
Q3 2023	$27.5M	$6.3M	-$1.17M	-15.6%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023	$28.7M	$6.91M	-$1.3M	-15.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$30M	$6.61M	-$1.18M	-15.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$31.1M	$7.69M	+$285K	+3.85%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-21
Q3 2022	$30.9M	$7.46M	+$324K	+4.54%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$30.5M	$8.21M	+$1.78M	+27.6%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$28.8M	$7.79M	+$2.55M	+48.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$26.2M	$7.4M	+$5.39M	+267%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$20.8M	$7.14M	+$5.88M	+469%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$14.9M	$6.43M	+$6.14M	+2095%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$8.8M	$5.24M	+$5.05M	+2686%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$3.75M	$2.02M			Oct 1, 2020	Dec 31, 2020	10-K	2022-02-24
Q3 2020		$1.25M	+$1.23M	+5352%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-09
Q2 2020		$293K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$188K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q3 2019		$23K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.